Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:15 pm Sale | 2025-06-30 | 13G | OUTLOOK THERAPEUTICS INC P OTLK | TANG CAPITAL MANAGEMENT, LLC | 1,500,000 3.400% | -400,000 (-21.05%) | Filing History |
| 2025-08-14 4:15 pm Sale | 2025-06-30 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | TANG CAPITAL MANAGEMENT, LLC | 169,999 4.800% | -25,516 (-13.05%) | Filing History |
| 2025-07-30 4:15 pm Unchanged | 2025-07-30 | 13G | ESSA PHARMA INC EPIX | TANG CAPITAL MANAGEMENT, LLC | 4,300,000 9.700% | 0 (Unchanged) | Filing History |
| 2025-07-22 4:31 pm Unchanged | 2025-07-18 | 13D | ITEOS THERAPEUTICS INC. ITOS | TANG CAPITAL MANAGEMENT, LLC | 3,826,692 9.990% | 0 (Unchanged) | Filing History |
| 2025-07-09 4:44 pm Purchase | 2025-07-07 | 13D | CARGO THERAPEUTICS INC CRGX | TANG CAPITAL MANAGEMENT, LLC | 3,059,630 6.600% | 330,342 (+12.10%) | Filing History |
| 2025-06-12 4:27 pm Unchanged | 2025-06-11 | 13D | ITEOS THERAPEUTICS INC. ITOS | TANG CAPITAL MANAGEMENT, LLC | 3,826,692 9.990% | 0 (Unchanged) | Filing History |
| 2025-05-23 4:15 pm Sale | 2025-05-21 | 13D | ACELYRIN INC SLRN | TANG CAPITAL MANAGEMENT, LLC | 0 0.000% | -8,824,693 (Position Closed) | Filing History |
| 2025-05-19 4:15 pm Sale | 2025-05-15 | 13D | ALLAKOS INC ALLK | TANG CAPITAL MANAGEMENT, LLC | 10,000 100.000% | -8,683,687 (-99.88%) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | ALX ONCOLOGY HLDGS INC ALXO | TANG CAPITAL MANAGEMENT, LLC | 3,158,265 5.900% | 3,158,265 (New Position) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | TANG CAPITAL MANAGEMENT, LLC | 190,639 9.900% | 190,639 (New Position) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | COMPASS THERAPEUTICS INC CMPX | TANG CAPITAL MANAGEMENT, LLC | 11,052,632 8.000% | 3,652,632 (+49.36%) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | CYBIN INC HELP | TANG CAPITAL MANAGEMENT, LLC | 1,830,097 9.100% | 500,000 (+37.59%) | Filing History |
| 2025-05-15 4:15 pm Sale | 2025-03-31 | 13G | CYTOMX THERAPEUTICS INC CTMX | TANG CAPITAL MANAGEMENT, LLC | 6,717,825 8.400% | -1,093,935 (-14.00%) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | EVOLUS INC EOLS | TANG CAPITAL MANAGEMENT, LLC | 4,997,399 7.900% | 150,000 (+3.09%) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | JOURNEY MED CORP COM DERM | TANG CAPITAL MANAGEMENT, LLC | 1,854,596 8.000% | 330,658 (+21.70%) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | TANG CAPITAL MANAGEMENT, LLC | 4,941,798 9.900% | 620,251 (+14.35%) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | OUTLOOK THERAPEUTICS INC P OTLK | TANG CAPITAL MANAGEMENT, LLC | 1,900,000 5.600% | 1,900,000 (New Position) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | TANG CAPITAL MANAGEMENT, LLC | 195,515 7.800% | 195,515 (New Position) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | ADICET BIO INC ACET | TANG CAPITAL MANAGEMENT, LLC | 513,976 9.900% | 416 (+0.08%) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | ELEVATION ONCOLOGY INC ELEV | TANG CAPITAL MANAGEMENT, LLC | 6,043,921 9.990% | 6,043,921 (New Position) | Filing History |